Cargando…

The relationship between insulin and glucagon concentrations in non‐diabetic humans

Abnormal postprandial suppression of glucagon in Type 2 diabetes (T2DM) has been attributed to impaired insulin secretion. Prior work suggests that insulin and glucagon show an inverse coordinated relationship. However, dysregulation of α‐cell function in prediabetes occurs early and independently o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laurenti, Marcello C., Arora, Praveer, Dalla Man, Chiara, Andrews, James C., Rizza, Robert A., Matveyenko, Aleksey, Bailey, Kent R., Cobelli, Claudio, Vella, Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277417/ https://www.ncbi.nlm.nih.gov/pubmed/35822422 http://dx.doi.org/10.14814/phy2.15380

Ejemplares similares

Glucagon-like peptide-1 receptor blockade impairs islet secretion and glucose metabolism in humans
por: Welch, Andrew A., et al.
Publicado: (2023)

Measurement of Pulsatile Insulin Secretion: Rationale and Methodology
por: Laurenti, Marcello C., et al.
Publicado: (2021)

Nonlinear Mixed Effects Modeling of Glucagon Kinetics in Healthy Subjects
por: Faggionato, Edoardo, et al.
Publicado: (2023)

Increased Rates of Meal Absorption Do Not Explain Elevated 1-Hour Glucose in Subjects With Normal Glucose Tolerance
por: Adams, Jon D, et al.
Publicado: (2018)

Contribution of Endogenous Glucagon-Like Peptide 1 to Glucose Metabolism After Roux-en-Y Gastric Bypass
por: Shah, Meera, et al.
Publicado: (2014)

The Oral Minimal Model Method
por: Cobelli, Claudio, et al.
Publicado: (2014)

Pulsatile Portal Vein Insulin Delivery Enhances Hepatic Insulin Action and Signaling
por: Matveyenko, Aleksey V., et al.
Publicado: (2012)

Effects of Type 2 Diabetes on Insulin Secretion, Insulin Action, Glucose Effectiveness, and Postprandial Glucose Metabolism
por: Basu, Ananda, et al.
Publicado: (2009)

Direct Effects of Exendin-(9,39) and GLP-1-(9,36)amide on Insulin Action, β-Cell Function, and Glucose Metabolism in Nondiabetic Subjects
por: Sathananthan, Matheni, et al.
Publicado: (2013)

Defective Glucagon-Like Peptide 1 Secretion in Prediabetes and Type 2 Diabetes Is Influenced by Weight and Sex. Chicken, Egg, or None of the Above?
por: Vella, Adrian, et al.
Publicado: (2015)

Three hours of intermittent hypoxia increases circulating glucose levels in healthy adults
por: Newhouse, Lauren P., et al.
Publicado: (2017)

Regenerative Medicine in Diabetes
por: Matveyenko, Aleksey, et al.
Publicado: (2015)

Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon‐like peptide‐1/glucagon receptor agonist SAR425899 in comparison with liraglutide
por: Schiavon, Michele, et al.
Publicado: (2021)

Common Genetic Variation in GLP1R and Insulin Secretion in Response to Exogenous GLP-1 in Nondiabetic Subjects: A pilot study
por: Sathananthan, Airani, et al.
Publicado: (2010)

Dipeptidyl Peptidase-4 Inhibition by Vildagliptin and the Effect on Insulin Secretion and Action in Response to Meal Ingestion in Type 2 Diabetes
por: Dalla Man, Chiara, et al.
Publicado: (2009)

Direct Effects of Exendin-(9,39) and GLP-1-(9,36)amide on Insulin Action, β-Cell Function, and Glucose Metabolism in Nondiabetic Subjects. Diabetes 2013;62:2752–2756
por: Sathananthan, M, et al.
Publicado: (2013)

Diabetes-Associated Common Genetic Variation and Its Association With GLP-1 Concentrations and Response to Exogenous GLP-1
por: Smushkin, Galina, et al.
Publicado: (2012)

Modeling Intraperitoneal Insulin Absorption in Patients with Type 1 Diabetes
por: Schiavon, Michele, et al.
Publicado: (2021)

The Effect of a Bile Acid Sequestrant on Glucose Metabolism in Subjects With Type 2 Diabetes
por: Smushkin, Galina, et al.
Publicado: (2013)

Exocrine and Endocrine Interactions in Cystic Fibrosis: A Potential Key to Understanding Insulin Secretion in Health and Disease?
por: Cobelli, Claudio, et al.
Publicado: (2017)

Quantitative Estimation of Insulin Sensitivity in Type 1 Diabetic Subjects Wearing a Sensor-Augmented Insulin Pump
por: Schiavon, Michele, et al.
Publicado: (2014)

The effect of vagal nerve blockade using electrical impulses on glucose metabolism in nondiabetic subjects
por: Sathananthan, Matheni, et al.
Publicado: (2014)

Diurnal Pattern to Insulin Secretion and Insulin Action in Healthy Individuals
por: Saad, Ahmed, et al.
Publicado: (2012)

PSUN137 Suppression of endogenous insulin secretion during euglycemic hyperinsulinemia – effects of obesity
por: Eyupoglu, Nesrin Damla, et al.
Publicado: (2022)

In Silico Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes
por: Schiavon, Michele, et al.
Publicado: (2020)

Diurnal Pattern of Insulin Action in Type 1 Diabetes: Implications for a Closed-Loop System
por: Hinshaw, Ling, et al.
Publicado: (2013)

Pregnancy glucagon-like peptide 1 predicts insulin but not glucose concentrations
por: Jones, Danielle L., et al.
Publicado: (2023)

Prandial Insulin and the Systemic Appearance of Meal-Derived Glucose in People With Type 1 Diabetes
por: Vella, Adrian, et al.
Publicado: (2008)

Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?
por: Butler, P. C., et al.
Publicado: (2009)

In silico design and validation of a time-varying PID controller for an artificial pancreas with intraperitoneal insulin delivery and glucose sensing
por: Dalla Libera, Alberto, et al.
Publicado: (2023)

Liver Enzymes Are Associated With Hepatic Insulin Resistance, Insulin Secretion, and Glucagon Concentration in Healthy Men and Women
por: Bonnet, Fabrice, et al.
Publicado: (2011)

Insulin and Glucagon: Partners for Life
por: Holst, Jens Juul, et al.
Publicado: (2017)

Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator
por: Visentin, Roberto, et al.
Publicado: (2016)

Impaired insulin signaling in unaffected siblings and patients with first episode psychosis
por: Chouinard, Virginie-Anne, et al.
Publicado: (2018)

Glucagon Supports Postabsorptive Plasma Glucose Concentrations in Humans With Biologically Optimal Insulin Levels
por: Cooperberg, Benjamin A., et al.
Publicado: (2010)

Correlation of circulating betatrophin concentrations with insulin secretion capacity, evaluated by glucagon stimulation tests
por: Tokumoto, S., et al.
Publicado: (2015)

Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose
por: Zhang, Yulin, et al.
Publicado: (2021)

Downregulation of the Longevity-Associated Protein Sirtuin 1 in Insulin Resistance and Metabolic Syndrome: Potential Biochemical Mechanisms
por: de Kreutzenberg, Saula Vigili, et al.
Publicado: (2010)

Interstitial Fluid Glucose Is Not Just a Shifted-in-Time but a Distorted Mirror of Blood Glucose: Insight from an In Silico Study
por: Cobelli, Claudio, et al.
Publicado: (2016)

Primary Defects in β-Cell Function Further Exacerbated by Worsening of Insulin Resistance Mark the Development of Impaired Glucose Tolerance in Obese Adolescents
por: Cali, Anna M.G., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_o0ge0p4vbhde6o2a6kclkr5j72